CARBOGEN AMCIS

CARBOGEN AMCIS is a leading contract development and manufacturing organisation (CDMO) delivering end-to-end solutions for the pharmaceutical and biopharmaceutical industries.

Founded in 1990 and headquartered in Switzerland, CARBOGEN AMCIS specialises in providing bespoke services across the entire drug development lifecycle. The company supports clients from early-stage development to commercial-scale manufacturing, ensuring the delivery of high-quality active pharmaceutical ingredients (APIs) and drug products. With a global presence and a network of state-of-the-art facilities, CARBOGEN AMCIS combines technical expertise, innovative technologies, and a customer-centric approach to accelerate time-to-market for its clients' therapeutic solutions.

Committed to sustainability and regulatory excellence, the company adheres to stringent environmental and safety standards. Its dedicated team of scientists and engineers work collaboratively with clients, tailoring solutions to meet the unique challenges of complex and highly potent molecules. CARBOGEN AMCIS serves a wide range of industries, including pharmaceuticals, biotechnology, and agrochemicals.

Key Products and Services:

• Custom Synthesis and Process Development: Comprehensive services for API synthesis, including route scouting, process optimisation, and scale-up.
• High Potency API (HPAPI) Manufacturing: Expertise in the development and production of highly potent compounds, including cytotoxics and hormones.
• Analytical Services: Advanced analytical testing and characterisation to ensure quality, safety, and compliance.
• Formulation Development and Manufacturing: Solutions for oral and injectable drug formulations, from development to clinical supply.
• Commercial Manufacturing: Large-scale production capabilities for APIs and intermediates, including controlled substances.
• Specialist Services: Expertise in hydrogenation, chromatography, and other specialised technologies.

With a reputation for reliability and innovation, CARBOGEN AMCIS continues to be a trusted partner for pharmaceutical and biopharmaceutical companies worldwide. By delivering tailored solutions and maintaining a strong focus on quality and sustainability, the company plays a vital role in advancing healthcare and improving patient outcomes.